Eurofins Scientific announced the closing of its acquisition of Infinity Laboratories, Inc. Founded in 1991, Infinity operates eight state-of-the-art laboratories across the United States and employs approximately 100 staff. Infinity’s significant microbiology testing footprint with best-in-class systems provides local services in key regions of the country, expanding the Eurofins microbiology footprint. The company also offers chemistry, sterilization, and package testing to pharmaceutical, biotechnology and medical device clients. Its package testing services in California provide an ideal complement to Eurofins’ Pennsylvania-based package testing services. Infinity’s core competencies, client relationships, and geographic coverage also complement and enhance the Eurofins network’s extensive portfolio in BioPharma Product Testing and Medical Device Testing services to clients across the United States and around the world.
The acquisition further bolsters the Eurofins BioPharma and Medical Device Testing network’s national and global footprint to provide the most comprehensive and competitive service offering in the industry. In return, Infinity and its clients gain access to Eurofins' extensive laboratory network, analytical portfolio and leading IT systems.
Comment from Dr Gilles Martin, Eurofins CEO: "We are very pleased to welcome Infinity’s teams to Eurofins. The addition of Infinity’s laboratories and competencies to Eurofins’ leading BioPharma Services network of companies further increases our leadership in providing the most innovative, high-quality and cost-competitive services and IT systems to our clients.”